Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of BG00012 in relapsing-remitting multiple sclerosis versus placebo and glatiramer acetate
2006-003697-10Phase 3Completed
- Sponsor
- Biogen
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dimethyl fumarate in multiple sclerosis (MS) (3 arms), sponsored by Biogen. Started Feb 2007; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-003697-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003697-10.